LEADER 00928nam a22002531i 4500 001 991002673899707536 005 20040225151350.0 008 040624s1970 xxua||||||||||||||||eng 020 $a0520015843 035 $ab12960196-39ule_inst 035 $aARCHE-091787$9ExL 040 $aDip.to Beni Culturali$bita$cA.t.i. Arché s.c.r.l. Pandora Sicilia s.r.l. 082 04$a930.1 100 1 $aClark, John Grahame Douglas$0103722 245 10$aAspects of prehistory /$cGrahame Clark 260 $aBerkeley [etc.] :$bUniversity of California Press,$c1970 300 $a161 p. :$bill. ;$c22 cm 650 4$aPreistoria 907 $a.b12960196$b02-04-14$c12-07-04 912 $a991002673899707536 945 $aLE001 H 41 8$g1$i2001000064120$lle001$nC. 1$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i13561480$z12-07-04 996 $aAspects of prehistory$9280145 997 $aUNISALENTO 998 $ale001$b12-07-04$cm$da $e-$feng$gxxu$h0$i1 LEADER 03930nam 22006735 450 001 9910254047703321 005 20200702144344.0 010 $a3-319-39926-8 024 7 $a10.1007/978-3-319-39926-3 035 $a(CKB)3710000000734984 035 $a(DE-He213)978-3-319-39926-3 035 $a(MiAaPQ)EBC4568533 035 $a(PPN)194379213 035 $a(EXLCZ)993710000000734984 100 $a20160623d2016 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aNovel Therapeutic Approaches to the Treatment of Parkinson?s Disease $eAn Overview and Update /$fedited by Corey R. Hopkins 205 $a1st ed. 2016. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016. 215 $a1 online resource (VII, 151 p. 20 illus., 10 illus. in color.) 225 1 $aTopics in Medicinal Chemistry,$x1862-2461 ;$v18 311 $a3-319-39924-1 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aAdenosine A2A Receptor Antagonists -- Targeting ?-Synuclein as a Parkinson?s Disease Therapeutic -- Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors. 330 $aMedicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors. 410 0$aTopics in Medicinal Chemistry,$x1862-2461 ;$v18 606 $aPharmaceutical chemistry 606 $aClinical biochemistry 606 $aProteins 606 $aMolecular biology 606 $aNeurochemistry 606 $aMedicinal Chemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/C28000 606 $aMedical Biochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/H35005 606 $aReceptors$3https://scigraph.springernature.com/ontologies/product-market-codes/L14110 606 $aMolecular Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B1700X 606 $aNeurochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/B18010 615 0$aPharmaceutical chemistry. 615 0$aClinical biochemistry. 615 0$aProteins. 615 0$aMolecular biology. 615 0$aNeurochemistry. 615 14$aMedicinal Chemistry. 615 24$aMedical Biochemistry. 615 24$aReceptors. 615 24$aMolecular Medicine. 615 24$aNeurochemistry. 676 $a616.83306 702 $aHopkins$b Corey R$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910254047703321 996 $aNovel Therapeutic Approaches to the Treatment of Parkinson?s Disease$92545270 997 $aUNINA LEADER 02009oas 2200865 a 450 001 9910144168303321 005 20251105213014.0 011 $a1573-5133 035 $a(DE-599)ZDB1497685-7 035 $a(DE-599)1497685-7 035 $a(OCoLC)42704616 035 $a(CONSER) 2004233252 035 $a(CKB)954925526825 035 $a(EXLCZ)99954925526825 100 $a19991026a19769999 sy a 101 0 $aeng 135 $aurmnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aEnvironmental biology of fishes 210 $a[Dordrecht] $cKluwer Academic Publishers 300 $aRefereed/Peer-reviewed 311 08$a0378-1909 606 $aFishes$xEcology$vPeriodicals 606 $aPoissons$xE?cologie$vPe?riodiques 606 $aFishes$xEcology$2fast$3(OCoLC)fst00926419 606 $aPeixos$2thub 606 $aEcologia$2thub 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 608 $aRevistes electròniques.$2thub 615 0$aFishes$xEcology 615 6$aPoissons$xE?cologie 615 7$aFishes$xEcology. 615 7$aPeixos. 615 7$aEcologia. 676 $a597 801 0$bF#A 801 1$bF#A 801 2$bOCLCQ 801 2$bGUA 801 2$bOCLCQ 801 2$bU9S 801 2$bCIT 801 2$bCUD 801 2$bQE2 801 2$bOCLCO 801 2$bMYG 801 2$bOCLCQ 801 2$bOCLCF 801 2$bOCLCQ 801 2$bJ9U 801 2$bVT2 801 2$bU3G 801 2$bSERSO 801 2$bDLC 801 2$bAU@ 801 2$bUKMGB 801 2$bCGU 801 2$bNJT 801 2$bSFB 801 2$bCNMTR 801 2$bOCLCO 801 2$bOCLCQ 801 2$bUAB 801 2$bAUD 801 2$bOCLCL 801 2$bADU 801 2$bLVT 801 2$bOCLCQ 906 $aJOURNAL 912 $a9910144168303321 996 $aEnvironmental biology of fishes$92233251 997 $aUNINA